Alkermes ALKS
NASDAQ ALKS
$41.75 +1.21 (+2.98%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alkermes (ALKS) Cost of Revenue (2010 - 2026)

Updated

Alkermes (ALKS) posted Cost of Revenue of $98.11 million for Q2 2026, up 98.4% from $49.46 million a year earlier and up 59.3% from the prior quarter.

Analysis

Alkermes (ALKS) Cost of Revenue (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cost of Revenue at Alkermes was $257.49 million, up 15.0% year-over-year; for FY2025, it was $196.46 million, down 19.9% from FY2024.

  • Annual Cost of Revenue shows a five-year compound annual growth rate of 2.0% (FY2020 to FY2025).
  • In prior years, Alkermes' Cost of Revenue was $245.33 million in FY2024 (-3.0%), $253.04 million in FY2023 (+16.0%), $218.07 million in FY2022 (+10.5%) and $197.32 million in FY2021 (+10.7%).
  • The Q2 2026 figure stands as the highest quarterly Cost of Revenue since Q2 2013.
  • On a year-over-year basis, Cost of Revenue increased in three of the last eight quarters, with growth averaging 4.4%.
  • The strongest year-over-year quarter for Cost of Revenue in the past five years was Q2 2026, with growth of 98.4%; the weakest was Q4 2025, with a decline of 25.6%.
  • According to Business Quant data, Cost of Revenue for the three prior quarters was $61.58 million (Q1 2026), $46.21 million (Q4 2025) and $51.59 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.05 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.29 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 2.52 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.58 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.09 Bn
10 Alkermes 6.99 Bn 4.13 Bn 397.90 Mn 98.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 98.11 Mn
Mar 31, 2026 61.58 Mn
Dec 31, 2025 46.21 Mn
Sep 30, 2025 51.59 Mn
Jun 30, 2025 49.46 Mn
Mar 31, 2025 49.20 Mn
Dec 31, 2024 62.12 Mn
Sep 30, 2024 63.10 Mn
Jun 30, 2024 61.47 Mn
Mar 31, 2024 58.64 Mn
Dec 31, 2023 70.13 Mn
Sep 30, 2023 61.50 Mn
Jun 30, 2023 63.25 Mn
Mar 31, 2023 58.16 Mn
Dec 31, 2022 53.92 Mn
Sep 30, 2022 50.63 Mn
Jun 30, 2022 58.36 Mn
Mar 31, 2022 55.16 Mn
Dec 31, 2021 53.62 Mn
Sep 30, 2021 49.56 Mn
API Access

Alkermes Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ALKS&period=max&api_key=YOUR_API_KEY